Induction of Krüppel-Like Factor 4 Mediates Polymorphonuclear Neutrophil Activation in Streptococcus pneumoniae

Aritra Bhattacharyya1, Toni Herta1, Claudia Conrad1

  • 1Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Frontiers in Microbiology
|February 22, 2021
PubMed

Insights

Streptococcus pneumoniae induces Krüppel-like factor 4 (KLF4) in polymorphonuclear neutrophils (PMNs). This KLF4 induction is essential for effective bacterial killing and modulating inflammatory responses during pneumococcal infections.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Polymorphonuclear neutrophils (PMNs) are crucial for combating bacterial infections.
  • Understanding the molecular mechanisms regulating PMN activation is vital for treating infections like those caused by Streptococcus pneumoniae.

Purpose of the Study:

  • To investigate the role of Krüppel-like factor 4 (KLF4) in Streptococcus pneumoniae-induced PMN activation.
  • To determine the signaling pathways involved in KLF4 induction by S. pneumoniae.

Main Methods:

  • Quantification of KLF4 expression in human and murine PMNs stimulated with S. pneumoniae.
  • Analysis of KLF4 induction by wild-type and mutant S. pneumoniae strains (e.g., capsule knockout, LytA mutants).
  • Assessment of PMN functions, including bacterial killing and cytokine release, following KLF4 knockdown in murine models.

Main Results:

  • S. pneumoniae time- and dose-dependently induces KLF4 expression in PMNs.
  • LytA-competent pneumococci and bacterial autolysis are required for KLF4 induction.
  • Unencapsulated S. pneumoniae mutants induced higher KLF4 levels than encapsulated wild-type strains.
  • KLF4 knockdown in mice impaired pneumococci killing and altered the release of pro- and anti-inflammatory cytokines (TNF-α, KC, IL-10).

Conclusions:

  • S. pneumoniae actively induces KLF4 expression in PMNs.
  • KLF4 plays a significant role in regulating PMN-mediated bacterial clearance and inflammatory responses during pneumococcal infections.
  • Targeting KLF4 may offer a therapeutic strategy for enhancing host defense against S. pneumoniae.